Sulfurimonas denitrificans Details: NCBI 39766, gram-negative or unknown [species]

| ATCC 33889| DSM 1251| Sulfurimonas denitrificans| Sulfurimonas denitrificans (Timmer-ten Hoor 1975) Takai et al. 2006| Thiomicrospira denitrificans| Thiomicrospira denitrificans Timmer-ten Hoor 1975 (Approved Lists 1980)

1. Co-infection with HBV: HDV can infect individuals who are already infected with HBV or can coinfect individuals concurrently with HBV. Coinfection with HDV and HBV can lead to a more severe form of acute hepatitis compared to HBV infection alone.

2. Superinfection: HDV can also cause superinfection in individuals who are already chronically infected with HBV. Superinfection with HDV in individuals with chronic HBV infection can lead to more severe liver disease, including fulminant hepatitis, liver cirrhosis, and hepatocellular carcinoma (liver cancer).

3. Chronic Hepatitis: Chronic infection with HDV can lead to chronic hepatitis delta, which can progress to cirrhosis and end-stage liver disease. Chronic hepatitis delta is associated with a higher risk of liver-related morbidity and mortality compared to chronic HBV infection alone.

4. Transmission: HDV is transmitted primarily through percutaneous exposure to infected blood or other body fluids. It can also be transmitted vertically from mother to child during childbirth and through sexual contact.

5. Global Impact: HDV infection is a significant public health concern globally, particularly in regions where HBV infection is endemic. It is estimated that there are approximately 15-20 million individuals worldwide who are chronically infected with HDV.

6. Prevention and Treatment: Prevention of HDV infection involves vaccination against HBV, as HDV requires HBV for its replication. Treatment options for chronic hepatitis delta are limited and often less effective compared to treatment for chronic HBV infection. Current treatment options include interferon-based therapies, but they are associated with limited efficacy and significant side effects. Research into new treatment strategies for hepatitis delta is ongoing.

Visuals of Interactions with other bacteria of the same rank

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

• Immune Epitope Database
• The NCBI taxonomy database
• UniProt
• Immune Epitope Taxonomy Database (IEDB)
• AI Engines For more Details: Perplexity  Kagi Labs  You 

More Information

Statistics

NCBI

Data Punk

End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Sulfurimonas denitrificans

• Frequency - how often do samples show this bacteria
• UD - An alternative statistical algorithm (which factors in the frequency)
• Kaltoft-Moldrup Heuristic Using uploaded data
• Lab Low and High are calculated using the formula that most labs use: Mean - 2 Standard Deviation to Mean + 2 Standard Deviation

These are values that are computed from lab specific samples (Patent Pending)

Lab	Frequency	UD-Low	UD-High	KM Low	KM High	Lab Low	Lab High	Mean	Median	Standard Deviation	Box Plot Low	Box Plot High	KM Percentile Low	KM Percentile High
Other Labs	0.13			1	10	0	14	4.3	2	4.9	1	10	20 %ile	60 %ile
thryve	0.09			0	162			162	162		162	162	0 %ile	99 %ile

External Reference Ranges for Sulfurimonas denitrificans

Sulfurimonas denitrificans (NCBI 39766) per million

Source of Ranges	Low Boundary	High Boundary	Low Boundary %age	High Boundary %age
PrecisionBiome	3.467073474894278E-05	3.467073474894278E-05	0	0

Statistic by Lab Source for Sulfurimonas denitrificans

These desired values are reported from the lab reports

Lab	Frequency Seen	Average	Standard Deviation	Sample Count	Lab Samples
CerbaLab	66.667 %	0 %	0 %	2.0	3
es-xenogene	3.125 %	0.001 %	%	1.0	32
Thorne	0.692 %	0 %	0 %	2.0	289
Thryve	0.065 %	0.016 %	%	1.0	1543

To see medical conditions associated you may be logged in

And display level must be raised above public.